维普中文期刊产品整合服务
2篇 您的检索式:作者名="Edgar R.Kramer"
    题名 作者 年代 出处 被引量
1The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system显示文摘Parkinson’s disease(PD)is the second most common neurodegenerative disease after Alzheimer’s disease.The etiology of PD is still not completely understood,but the degeneration of dopaminergic(DA)neurons in the substantia nigra pars compacta(SNpc),loss of DA innervation of the striatum,and protein aggregates in the form of Lewy bodies and neuritesEdgar R.Kramer 2015Neural Regeneration Research2015,10,11:2
2Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease?A discussion of data from the culture dish to the clinic显示文摘The neurotrophic signaling of glial cell line-derived neurotrophic factor(GDNF)with its canonical receptor,the receptor tyrosine kinase RET,coupled together with the GDNF family receptor alpha 1 is important for dopaminergic neuron survival and physiology in cell culture experiments and animal models.This prompted the idea to try GDNF/RET signaling as a therapeutic approach to treat Parkinson’s disease with the hallmark of dopaminergic cell death in the substantia nigra of the midbrain.Despite several clinical trials with GDNF in Parkinson’s disease patients,which mainly focused on optimizing the GDNF delivery technique,benefits were only seen in a few patients.In general,the endpoints did not show significant improvements.This suggests that it will be helpful to learn more about the basic biology of this fascinating but complicated GDNF/RET signaling system in the dopaminergic midbrain and about recent developments in the field to facilitate its use in the clinic.Here we will refer to the latest publications and point out important open questions in the field.James A.Conway Edgar R.Kramer 2022Neural Regeneration Research2022,17,7:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费